MedTrace Logo

The Predictive Value of Modified EASIX Score for Determining Erectile Dysfunction Severity

NCT07274982 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 380

Last updated 2025-12-10

No results posted yet for this study

Summary

This retrospective single-center case-control study evaluates whether the Modified EASIX score (LDH × CRP / Platelets), calculated from routine blood tests, predicts severity of erectile dysfunction (ED) as measured by the IIEF-5 questionnaire. Medical records from January 1, 2024 to September 30, 2025 will be reviewed. Patients will be classified by IIEF-5 (≤21 = ED; ≥22 = no ED) and Modified EASIX distributions and predictive performance (ROC/AUC) will be compared between groups. No additional interventions will be performed.

Conditions

  • Erectile Dysfunctions
  • Endothelial Dysfunction
  • Inflammation

Interventions

OTHER

IIEF-5

IIEF-5: The erectile dysfunction status of patients will be analyzed with the International Index of Erectile Function-5.

OTHER

mEASIX

Endothelial function will be evaluated with mEAX.

Sponsors & Collaborators

  • Ministry of Health, Turkey

    collaborator OTHER_GOV

  • Ataturk University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2025-11-15
Completion
2025-11-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07274982 on ClinicalTrials.gov